Double Bond Pharmaceutical International notifies availability of press release

Reuters2026/07/21 12:48

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Double Bond Pharmaceutical International AB released a press statement on SI053 (Temodex) real-world evidence data accepted for presentation at SNO 2026.
The Society for Neuro-Oncology annual meeting runs Nov. 12-15, 2026 in Philadelphia; the abstract is due in a Neuro-Oncology journal supplement.
Company link: https://mb.cision.com/Main/12720/4307158/3933333.pdf

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Double Bond Pharmaceutical International AB published the original content used to generate this news brief via Cision (Ref. ID: 20260721:BIT:0733:0) on July 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Double Bond Pharmaceutical International notifies availability of press release

You may also like

Crypto prices